Physicians may be able to determine if menopause-related bone loss is already in progress or about to begin by measuring the level of a hormone called anti-Mullerian hormone that declines as women approach their final menstrual period. The findings could help physicians determine when, and how, to treat bone loss in women as they age before that bone loss causes significant health issues.
